Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Starting soon

Conditions studied: Mantle Cell Lymphoma

In brief

Clinical studies with a distinct emphasis on mantle cell lymphoma play a pivotal role in evaluating the safety and effectiveness of novel treatments for this disease. These trials are instrumental in ascertaining whether new medications surpass conventional therapies, providing substantial evidence to endorse their broad utilization. This particular study stands out as it centers on the firsthand experiences of individuals battling mantle cell lymphoma who are actively engaged in a clinical trial featuring medicinal interventions. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this patient group.

Key facts

Study ID

NCT06049472

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-10-01

Expected to finish

2026-10-01

Last updated by the study team

2023-09-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of mantle cell lymphoma
• No serious medical or psychiatric illness likely to interfere with participation in this clinical study.
• Ability to understand and the willingness to sign a written informed consent document.

You may not qualify if…

• Concurrent participation in another therapeutic clinical trial.
• Subject has an uncontrolled infection
• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.